Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Saved in:
| Title: | Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study. |
|---|---|
| Authors: | Belani CP (AUTHOR), Brodowicz T (AUTHOR), Ciuleanu TE (AUTHOR), Krzakowski M (AUTHOR), Yang SH (AUTHOR), Franke F (AUTHOR), Cucevic B (AUTHOR), Madhavan J (AUTHOR), Santoro A (AUTHOR), Ramlau R (AUTHOR), Liepa AM (AUTHOR), Visseren-Grul C (AUTHOR), Peterson P (AUTHOR), John WJ (AUTHOR), Zielinski CC (AUTHOR) |
| Source: | Lancet Oncology. Mar2012, Vol. 13 Issue 3, p292-299. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
